R162
R162 Basic information
- Product Name:
- R162
- Synonyms:
-
- R162;R-162;R 162
- R162, >98%
- 2-Allyl-1-hydroxy-9,10-anthraquinone
- 9,10-Anthracenedione, 1-hydroxy-2-(2-propen-1-yl)-
- R162,inhibit,R-162,Inhibitor,R 162
- 9,10-Anthracenedione, 1-hydroxy-2-(2-propenyl)-
- R162, 10 mM in DMSO
- 2-ALLYL-1-HYDROXY-ANTHRAQUINONE
- CAS:
- 64302-87-0
- MF:
- C17H12O3
- MW:
- 264.28
- Mol File:
- 64302-87-0.mol
R162 Chemical Properties
- Melting point:
- 120-120.5 °C(Solv: acetone (67-64-1))
- Boiling point:
- 459.0±34.0 °C(Predicted)
- Density
- 1.308±0.06 g/cm3(Predicted)
- storage temp.
- -20°C
- solubility
- Soluble in DMSO (up to 10 mg/ml or in Ethanol (up to 5 mg/ml)
- form
- solid
- pka
- 7.43±0.20(Predicted)
- color
- Orange
- Stability:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.
R162 Usage And Synthesis
Description
R162 (64302-87-0) is a selective inhibitor of glutamate dehydrogenase 1 (GDH1), a commonly upregulated enzyme in human cancers (Ki?= 28.6 μM).? It does not inhibit the activity of other NADPH enzymes such as 6-phosphogluconate dehydrogenase and fumarate hydratase. R162 treatment leads to decreased fumarate levels, lower glutathione peroxidase activity, increased ROS levels and reduced cell proliferation in H1299 and MDA-MB231 cells.? R162 sensitizes LKB-1 deficient tumor cells to anoikis induction.? R162 treatment (at 20 mg/kg/day) significantly attenuates metastatic potential in a xenograft mouse model.2? GDH1 is a promising antimetastasis target and R162 is a useful tool for proof of principal studies.
Uses
R162 is a glutamate dehydrogenase 1 inhibitor for the treatment of cancer. A useful bioactive chemical compound.
Definition
ChEBI: 2-allyl-1-hydroxy-9,10-anthraquinone is a monohydroxyanthraquinone that is 9,10-anthraquinone in which the hydrogens at positions 1 and 2 are replaced by a hydroxy and an allyl group, respectively. It has a role as an EC 1.4.1.3 {glutamate dehydrogenase [NAD(P)(+)]} inhibitor.
in vivo
R162 (30 mg/kg/day, i.p.) does not result in a significant histopathological change between the vehicle-treated and R162-treated groups, nor alters complete blood counts, or hematopoietic properties in xenograft tumor mouse models. R162 (20 mg/kg/day) results in significantly decreased tumor growth and masses in mice compared with control mice and effectively inhibits GDH1 activity in resected tumors from xenograft nude mice[1].
References
[1] LINGTAO JIN. Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth.[J]. Cancer Cell, 2015, 27 2: 257-270. DOI:10.1016/j.ccell.2014.12.006
[2] LINGTAO JIN. The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung Cancer.[J]. Molecular Cell, 2018, 69 1: 87-99.e7. DOI:10.1016/j.molcel.2017.11.025
R162Supplier
- Tel
- 021-58955995
- sales@medchemexpress.cn
- Tel
- 025-846993838003-8003 18013301590
- njduly@126.com
- Tel
- 13621943973
- sales@shjiyipharmatech.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com